Doctor profile · Federal record

Dr. Catherine Kowal, MD

Rheumatology Physician (CMS: Rheumatology) · Naples, FL

  • NPI 1013909332
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 41 yrs in practice
  • Female
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1855 Veterans Park Dr, Suite 103
Naples, FL 341090446
(239) 596-5220
fax (239) 643-9816

Credentials & registration

NPPES · NUCC
NPI registered
August 2005 — 21 yrs on file
Profile last updated
April 28, 2022
Year of graduation
1985 — 41 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Florida #ME62925
Medicaid
FL #373916300

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1013909332. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
208,837
Distinct HCPCS
10
Medicare allowed
$2,392,816
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 115,200 59 $5
J3262 Injection, tocilizumab, 1 mg 37,040 27 $6
J1602 Injection, golimumab, 1 mg, for intravenous use 18,127 38 $13
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 17,750 43 $42
J3111 Injection, romosozumab-aqqg, 1 mg 9,870 11 $10
J0897 Injection, denosumab, 1 mg 5,880 69 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,180 18 $33
99214 Established patient office or other outpatient visit, 30-39 minutes 799 461 $132
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 730 139 $75
96413 Administration of chemotherapy into vein, 1 hour or less 502 131 $134

In context: peer comparison

Among 3 peers in Naples Rheumatology Physician, average services per provider: 10,895. This provider delivers 19× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$4,109
Transactions
176
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 21 $470.88
Amgen INC. 32 $454.21
Ucb, INC. 27 $428.27
AstraZeneca Pharmaceuticals Lp 10 $426.12
Abbvie INC. 14 $384.26
Genzyme Corporation 6 $331.12
Janssen Biotech, INC. 6 $211.92
Mallinckrodt Hospital Products INC. 11 $203.98
E.R. Squibb & Sons, L.L.C. 8 $199.10
Lilly USA, LLC 9 $193.62
Pfizer INC. 12 $183.22
GlaxoSmithKline, LLC. 11 $178.15
Genentech USA, INC. 3 $70.30
Fresenius Kabi USA, LLC 3 $67.69
Alexion Pharmaceuticals, INC. 3 $58.10

By nature of payment

Food and Beverage
$4,109

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,180
Patients
644
Total drug cost
$631,576
Drug Type Claims Patients Total cost
Prednisone Generic 430 131 $4,073
Hydroxychloroquine Sulfate Generic 425 126 $23,503
Methotrexate (Methotrexate Sodium) Brand 396 109 $14,964
Celecoxib Generic 152 48 $6,286
Gabapentin Generic 114 32 $2,769
Folic Acid Generic 106 32 $502
Methylprednisolone Generic 103 60 $2,946
Meloxicam Generic 85 26 $746
Enbrel Sureclick (Etanercept) Brand 70 0 $565,118
Tramadol Hcl Generic 67 22 $468

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Catherine Kowal's medical specialty?
Dr. Catherine Kowal practices Rheumatology Physician in Naples, FL.
Where does Dr. Catherine Kowal practice?
Dr. Catherine Kowal practices at 1855 Veterans Park Dr, Naples, FL 341090446. Office phone: 2395965220.
What is Dr. Catherine Kowal's NPI?
Dr. Catherine Kowal's National Provider Identifier (NPI) is 1013909332, issued by NPPES.
Does Dr. Catherine Kowal accept Medicare assignment?
Yes. Dr. Catherine Kowal accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Catherine Kowal commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602). Source: CMS Medicare Physician & Other Practitioners file.